Skip to main content
Clinical Trials/NCT06158893
NCT06158893Not yet recruitingPhase 4

Comparison of Preoperative Inhaled Budesonide With Salbutamol on the Respiratory Adverse Effects in Children Undergoing Tonsillectomy

Assiut University0 sites87 target enrollmentStarted: August 2024Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Enrollment
87
Primary Endpoint
incidence of preoperative respiratory adverse events.

Study Overview

Brief Summary

Comparison of preoperative inhaled Budesonide with Salbutamol on the incidence of respiratory adverse effects in children undergoing tonsillectomy

Detailed Description

Comparison of preoperative inhaled Budesonide with Salbutamol on the incidence of respiratory adverse effects in children undergoing tonsillectomy Adenotosillectomy is routinely performed for children with sleep disordered breathing or recurrent infectious tonsillitis. Although the safety of the pediatric anesthesia is constantly improving, a substantial proportion of children undergoing tonsillectomies experience pre operative respiratory adverse events with a prevalence up to 50% in children with at least one risk factor. Both minor adverse effects such as oxygen desaturation airway, obstruction coughing or wheezing and the major events such as laryngospasm and/ or bronchospasm occur more commonly undergoing tonsillectomy compared with other non airway surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
5 Years to 12 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • children scheduled for elective tonsillectomy with or without adenoidectomy, grommets cautery of inferior turbinates.
  • Age more than or equal 5 years and less than or equal to 12 years.
  • Both genders
  • No obvious abnormalities in preoperative ECG, blood routine electrolytes and other tests.
  • ASA class 1

Exclusion Criteria

  • Patients with Known hypersensitivity to any of the drugs that would be used in the study
  • Patients that are immunologically compromised
  • Sleep apnea syndrome or difficult airway
  • Pre-existing hypoxemia is SpO2 < 90%
  • History of adverse events with prior sedation or patients who had taken any sedative drugs within the last 24 hours.
  • Parents refusal

Arms & Interventions

normal saline

Placebo Comparator

children will receive 0.4 ml of normal saline 0.9 by inhalation 20 minutes preoperatively

Intervention: Saline (Other)

salbutamol

Experimental

children will receive 0.15 milligram per kilogram of salbutamol diluted with normal saline to a total volume of 4 ml by inhalation 20 minutes preoperatively

Intervention: Salbutamol (Drug)

budesonide

Active Comparator

children will receive 0.5 milligram per kilogram of budesonide diluted with normal saline to a total volume of 4 ml by inhalation 20 minutes preoperatively

Intervention: Budesonide (Drug)

Outcomes

Primary Outcomes

incidence of preoperative respiratory adverse events.

Time Frame: 1 year

Will be the incidence of preoperative respiratory adverse events. events will be reported by the attending an anesthetist or PACU nurse on a dedicated data collection sheet and will be recorded against the phase of anesthesia (induction, maintenance, emergency, or recovery) during which the event occurred

Secondary Outcomes

  • frequency of the individual PRAEs(1 year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ziad Shaban Redwan Helal

Resident Doctor

Assiut University

Similar Trials